Omadacycline: a review of the clinical pharmacokinetics and pharmacodynamics

KA Rodvold, RM Burgos, X Tan, MP Pai - Clinical pharmacokinetics, 2020 - Springer
… to a successful drug development program and US Food and Drug Administration (FDA) …
provides a comprehensive summary of the clinical pharmacokinetic and pharmacodynamic

A practical guide to secondary pharmacology in drug discovery

S Jenkinson, F Schmidt, LR Ribeiro… - … of Pharmacological and …, 2020 - Elsevier
… in pharmaceutical drug discovery to address unwanted pharmacological side effects of
drug … allows to exploit synergies for comprehensive safety assessment of drug candidates. …

Preclinical pharmacokinetic/pharmacodynamic studies and clinical trials in the drug development process of EMA-approved antibacterial agents: a review

A Jorda, M Zeitlinger - Clinical Pharmacokinetics, 2020 - Springer
pharmacokinetic/pharmacodynamic studies in dosing optimization and decision making in
antimicrobial drug development. … a comprehensive review of the development process of all …

Machine learning approaches and their applications in drug discovery and design

S Priya, G Tripathi, DB Singh, P Jain… - … Biology & Drug Design, 2022 - Wiley Online Library
drug discovery. Many physicochemical properties of drugs like toxicity, absorption, drugdrug
tremendous potential in the field of drug discovery. Techniques discussed in this review …

… of malignant tumors of the female reproductive system: A review of traditional Chinese medicinal uses, phytochemistry, pharmacokinetics, and pharmacodynamics

X Pan, Q Shen, C Zhang, X Zhang, Y Li… - Frontiers in …, 2023 - frontiersin.org
… and inform novel drug development for treating … integration effect for the identification of
more lead compounds that could be the foundation for the discovery of new anti-tumor drugs. …

Approaches to dose finding in neonates, illustrating the variability between neonatal drug development programs

JN Van den Anker, S McCune, P Annaert, GR Baer… - Pharmaceutics, 2020 - mdpi.com
Drug dosing in neonates should be based on integrated knowledge concerning the disease
… neonate, and the pharmacokinetics (PK) and pharmacodynamics (PD) of a given drug. It is …

Adverse drug reactions of acetylcholinesterase inhibitors in older people living with dementia: a comprehensive literature review

S Ruangritchankul, P Chantharit… - … and Clinical Risk …, 2021 - Taylor & Francis
… in pharmacokinetics (PK), pharmacodynamics (PD) and pharmacogenetics (PGx), and
occurrence of drug … To date, comprehensive reviews in ADRs of AChEIs have so far been scarcely …

Phase 1 studies to define the safety, tolerability, and pharmacokinetic and pharmacodynamic profiles of the nonsteroidal mineralocorticoid receptor antagonist …

T Nakamura, A Kawaguchi - … in Drug Development, 2021 - Wiley Online Library
Apararenone is a long‐acting, nonsteroidal mineralocorticoid receptor antagonist (MRA). The
safety, tolerability, and pharmacokinetic (PK) and pharmacodynamic (PD) profiles of single…

ChatGPT in drug discovery

G Sharma, A Thakur - 2023 - chemrxiv.org
drug to market;16 (4) Stringent regulatory requirements: The process of drug development is
heavily regulated, and drugsdrug development: Even after a drug has been identified and …

Druggability and drug-likeness concepts in drug design: are biomodelling and predictive tools having their say?

C Agoni, FA Olotu, P Ramharack… - Journal of molecular …, 2020 - Springer
discovery field. Herein, we present the different … in the drug discovery domain. We believe
that this report would serve as a comprehensive guide towards computational-oriented drug